Over 90% of ECs exhibit genomic alteration of the PI3K/Akt pathway (6), due to two main factors: (1) direct activation by the aforementioned obesity-related factors and (2) the high frequency of mutations in PIK3CA, PIK3R1, and PTEN found in EC. This evidence concerns the gene AKT1 and obesity disorder.